MarcLevesqueMD

PubMed

• 9 citations
  Lung gene expression and single cell analyses reveal two subsets of idiopathic pulmonary fibrosis (IPF) patients associated with different pathogenic mechanisms.
  Jozsef Karman, Jing Wang, Corneliu A Bodea, Sherry Cao, Marc C. Levesque> ;Plos One. 2021 Mar 23
• 14 citations
  Diminished cytokine-induced Jak/STAT signaling is associated with rheumatoid arthritis and disease activity
  Jason Ptacek, Rachael E. Hawtin, Dongmei Sun, Brent Louie, Erik Evensen, Barbara B. Mittleman, Alessandra Cesano, Guy Cavet, Clifton O. Bingham, Stacey S. Cofield, Jef...> ;Plos One. 2021 Jan 14
• Response to: 'Can IL-1 be used as a target for osteoarthritis?' by Cheng et al.
  M. Kloppenburg, Marc C. Levesque> ;Annals of the Rheumatic Diseases. 2020 Jul 1
• 4 citations
  Longitudinal Reliability of the OMERACT Thumb Base Osteoarthritis Magnetic Resonance Imaging Scoring System (TOMS).
  Féline P B Kroon, Sjoerd van Beest, Frédérique Gandjbakhch, Charles Peterfy, Su Chen, Philip G. Conaghan, Iris Eshed, Violaine Foltz, Harry K. Genant, Ida K. Haugen, J...> ;The Journal of Rheumatology. 2019 Sep 1
• 115 citations
  A Phase II Trial of Lutikizumab, an Anti-Interleukin-1α/β Dual Variable Domain Immunoglobulin, in Knee Osteoarthritis Patients With Synovitis.
  Roy Fleischmann, Henning Bliddal, Francisco J. Blanco, Thomas J. Schnitzer, Charles Peterfy, Su Chen, Li Wang, Sheng Feng, Philip G. Conaghan, Francis Berenbaum, Jean-...> ;Arthritis & Rheumatology. 2019 Jul 1
• 93 citations
  Phase IIa, placebo-controlled, randomised study of lutikizumab, an anti-interleukin-1α and anti-interleukin-1β dual variable domain immunoglobulin, in patients with er...
  Margreet Kloppenburg, Charles Peterfy, Ida K. Haugen, Féline P B Kroon, Su Chen, Li Wang, Wei Liu, Gwen Levy, Roy Fleischmann, Francis Berenbaum, Désirée van der Heijd...> ;Annals of the Rheumatic Diseases. 2019 Mar 1
• 6 citations
  Novel methodology to discern predictors of remission and patterns of disease activity over time using rheumatoid arthritis clinical trials data
  Bdm Tom, Deborah P M Symmons, Sarah Brockbank, Claudio Carini, Andrew P. Cope, Ehrenstein, Benjamin A Fisher, Carl S. Goodyear, Neil Gozzard, Ray Harris, K Hicks, Sall...> ;RMD Open. 2018 Oct 25
• 4 citations
  Timing and Impact of Decisions to Adjust Disease-Modifying Antirheumatic Drug Therapy for Rheumatoid Arthritis Patients With Active Disease.
  Yomei Shaw, Chung-Chou H. Chang, Marc C. Levesque, Julie M. Donohue, Kaleb Michaud, Mark S. Roberts> ;Arthritis Care & Research. 2018 Jun 1
• 15 citations
  Rheumatoid Arthritis Patients' Motivations for Accepting or Resisting Disease-Modifying Antirheumatic Drug Treatment Regimens.
  Yomei Shaw, Ilinca D. Metes, Kaleb Michaud, Julie M. Donohue, Mark S. Roberts, Marc C. Levesque, Judy C. Chang> ;Arthritis Care & Research. 2018 Apr 1
• 2 citations
  Corrigendum: The RA-MAP Consortium: a working model for academia-industry collaboration.
  Andrew P. Cope, Michael R. Barnes, Alexandra Belson, Michael Binks, Sarah Brockbank, Francisco Bonachela-Capdevila, Claudio Carini, Benjamin A Fisher, Carl S. Goodyear...> ;Nature Reviews. Rheumatology. 2018 Jan 24
• 11 citations
  The RA-MAP Consortium: a working model for academia-industry collaboration
  Andrew P. Cope, Michael R. Barnes, Alexandra Belson, Michael Binks, Sarah Brockbank, Francisco Bonachela-Capdevila, Claudio Carini, Benjamin A Fisher, Carl S. Goodyear...> ;Nature Reviews. Rheumatology. 2018 Jan 1
• 4 citations
  Phase 2 to phase 3 clinical trial transitions: Reasons for success and failure in immunologic diseases.
  Dhavalkumar D. Patel, Christian Antoni, Steven J. Freedman, Marc C. Levesque, John S. Sundy> ;The Journal of Allergy and Clinical Immunology. 2017 Sep 1
• 19 citations
  Erratum to: Autoantibody levels in myositis patients correlate with clinical response during B cell depletion with rituximab [Rheumatology, 55 (991-999) (2016)] DOI:10...
  Rohit Aggarwal, Chester V. Oddis, Danielle Goudeau, Diane Koontz, Zengbiao Qi, Ann M. Reed, Dana P. Ascherman, Marc C. Levesque> ;Rheumatology. 2016 Sep 1
• 20 citations
  Autoantibody levels in myositis patients correlate with clinical response during B cell depletion with rituximab.
  Rohit Aggarwal, Chester V Oddis, Danielle Goudeau, Diane Koontz, Zengbiao Qi, Ann M Reed, Dana P Ascherman, Marc C Levesque> ;Rheumatology. 2016 Jun 1
• 43 citations
  Differential response of serum amyloid A to different therapies in early rheumatoid arthritis and its potential value as a disease activity biomarker
  Yong Gil Hwang, Goundappa K. Balasubramani, Ilinca D. Metes, Marc C. Levesque, S. Louis Bridges, Larry W. Moreland> ;Arthritis Research & Therapy. 2016 May 17
• 7 citations
  IgG4-Related Lung Disease Associated with Usual Interstitial Pneumonia
  Frank Schneider, Kristen L. Veraldi, Marc C. Levesque, Thomas V. Colby, Eunhee S. Yi> ;The Open Rheumatology Journal. 2016 Mar 17
• 4 citations
  Agreement of Physicians and Nurses Performing Tender and Swollen Joint Counts in Rheumatoid Arthritis.
  Christine L. Amity, Elizabeth A. Schlenk, Kenneth N. Gold, Marisa M. Eckels, Niveditha Mohan, Goundappa K. Balasubramani, Stephen R. Wisniewski, Marc C. Levesque, Tere...> ;Journal of Clinical Rheumatology. 2016 Jan 1
• 33 citations
  Increased pretreatment serum IFN-β/α ratio predicts non-response to tumour necrosis factor α inhibition in rheumatoid arthritis
  Theresa Wampler Muskardin, Priyanka Vashisht, Jessica M. Dorschner, Mark A. Jensen, Beverly S. Chrabot, Marlena Kern, Jeffrey R. Curtis, Maria I. Danila, Stacey S. Cof...> ;Annals of the Rheumatic Diseases. 2016 Oct 1
• 36 citations
  Biologic predictors of clinical improvement in rituximab-treated refractory myositis.
  Ann M. Reed, Cynthia S. Crowson, Molly S. Hein, Consuelo M. Lopez De Padilla, Jeannette M. Olazagasti, Rohit Aggarwal, Dana P. Ascherman, Marc C. Levesque, Chester V. ...> ;BMC Musculoskeletal Disorders. 2015 Sep 17
• 11 citations
  Interferon-regulated chemokine score associated with improvement in disease activity in refractory myositis patients treated with rituximab.
  Consuelo M. Lopez De Padilla, Cynthia S. Crowson, Molly S. Hein, Michael A. Strausbauch, Rohit Aggarwal, Marc C. Levesque, Dana P. Ascherman, Chester V. Oddis, Ann M. ...> ;Clinical and Experimental Rheumatology. 2015 Sep 1
• 14 citations
  Type I interferon and T helper 17 cells co-exist and co-regulate disease pathogenesis in lupus patients.
  Partha S. Biswas, Rohit Aggarwal, Marc C. Levesque, Kelly Maers, Kritika Ramani> ;International Journal of Rheumatic Diseases. 2015 Jul 1
• 27 citations
  Anti-signal recognition particle autoantibody ELISA validation and clinical associations
  Rohit Aggarwal, Chester V. Oddis, Danielle Goudeau, Noreen Fertig, Ilinca D. Metes, Chad Stephens, Zengbiao Qi, Diane Koontz, Marc C. Levesque> ;Rheumatology. 2015 Jul 1
• 20-year-old amish woman with abdominal pain, retroperitoneal mass, and hyperlipidemia.
  Ximena D. Ruiz, Marc C. Levesque, Swati R. Modi, Gregory D. Mock, Kimberly P. Liang> ;Arthritis Care & Research. 2015 Mar 1
• 187 citations
  Treatment of Lupus Nephritis with Abatacept: The Abatacept and Cyclophosphamide Combination Efficacy and Safety Study
  Anca Askanase, Margie Byron, Lynette Keyes-Elstein, Patricia Cagnoli, W. Joseph McCune, W. Winn Chatham, Gabriel Contreras, David I. Daikh, Maria Dall'Era, David Wofsy...> ;Arthritis & Rheumatology. 2014 Nov 1
• 15 citations
  Complement Component C5a Permits the Coexistence of Pathogenic Th17 Cells and Type I IFN in Lupus
  Sudesh Pawaria, Kritika Ramani, Kelly Maers, Youhua Liu, Lawrence P. Kane, Marc C. Levesque, Partha S. Biswas> ;Journal of Immunology. 2014 Oct 1
• Join now to see all